Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/17/2012US8158656 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
04/17/2012US8158655 Sulfonamide derivatives
04/17/2012US8158654 Pyridine non-classical cannabinoid compounds and related methods of use
04/17/2012US8158653 For reducing levels of tumor necrosis factor alpha in mammals; 3-(1-Oxo-4-aminoisoindolin-1-yl)-3-methylpiperidine-2,6 dione; 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline
04/17/2012US8158652 Substituted pyridone derivative
04/17/2012US8158651 Fentanyl composition for nasal administration
04/17/2012US8158650 Substituted phenylmethyl bicyclocarboxyamide compounds
04/17/2012US8158649 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
04/17/2012US8158648 Heteroaryl 11-beta hydroxysteroid dehydrogenase type I inhibitors
04/17/2012US8158647 Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
04/17/2012US8158646 Antifungal and antiparasitic indoloquinoline derivates
04/17/2012US8158645 Compound, corresponding compositions, preparation and/or treatment methods
04/17/2012US8158644 Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
04/17/2012US8158643 Substituted diaza-spiro-pyridinone derivatives for use in MCH-1 mediated diseases
04/17/2012US8158642 Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
04/17/2012US8158641 2-anilino-4-aminoalkyleneaminopyrimidines
04/17/2012US8158640 Tetrahydroquinoline derivatives and a process for preparing the same
04/17/2012US8158639 Non-sedating barbiturate compounds as neuroprotective agents
04/17/2012US8158638 Pyrazolopyrimidine derivative
04/17/2012US8158637 Sodium channel moderators; antiarrhythmia agents; analgesics; antiarthritic agents; antiinflammatory agents; antieplipetic agents; psychological disorders; nervous system disorders
04/17/2012US8158636 Compounds and methods for kinase modulation, and indications therefor
04/17/2012US8158635 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
04/17/2012US8158634 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
04/17/2012US8158633 Phenyl-substituted pyrazolopyrimidines
04/17/2012US8158632 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
04/17/2012US8158631 Heterocyclic antiviral compounds
04/17/2012US8158630 Application of 2,5 -dihydroxymethyl-3,6-dimethyl pyrazine and its derivates in pharmacy
04/17/2012US8158629 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
04/17/2012US8158628 Sulfonylated 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine compounds and their use as pharmaceuticals
04/17/2012US8158627 Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
04/17/2012US8158626 Thiazolopyrimidine PI3K inhibitor compounds and methods of use
04/17/2012US8158625 Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
04/17/2012US8158624 Purine PI3K inhibitor compounds and methods of use
04/17/2012US8158623 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
04/17/2012US8158622 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
04/17/2012US8158621 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
04/17/2012US8158620 Fused aminodihydrothiazine derivatives
04/17/2012US8158619 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use
04/17/2012US8158618 Dibenzothiazepine derivatives and uses thereof—424
04/17/2012US8158617 Fused heterocyclic compound and use thereof
04/17/2012US8158616 Azetidine and cyclobutane derivatives as JAK inhibitors
04/17/2012US8158615 Anti-viral composition for the topical treatment of Herpes Labialis (cold sores) and method for use thereof
04/17/2012US8158614 Therapeutic treatment of cancer and dysplasia of the cervix or vagina using estrogen antagonists
04/17/2012US8158613 Topical pharmaceutical formulations and methods of treatment
04/17/2012US8158612 Methods of treating disease states using antiangiogenic agents
04/17/2012US8158611 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
04/17/2012US8158610 Dextrin-containing composition for preventing surgical adhesions
04/17/2012US8158609 Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
04/17/2012US8158608 Bioactive fraction from Zingier officinale and a process for the preparation thereof
04/17/2012US8158607 Crystalline form of lamivudine
04/17/2012US8158606 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies
04/17/2012US8158605 Azacytidine analogues and uses thereof
04/17/2012US8158604 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
04/17/2012US8158601 Lipid formulation
04/17/2012US8158600 Methods and compositions for detecting and treating retinal diseases based on metargidin (ADAM-15)
04/17/2012US8158598 Compositions and their uses directed to PTPR alpha
04/17/2012US8158597 Modulation of diacylglycerol acyltransferase 1 expression
04/17/2012US8158592 for treatment of atopic conditions (dermatitis, allergies); point mutations; immunotherapy
04/17/2012US8158591 Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines
04/17/2012US8158585 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
04/17/2012US8158575 Agent for the prevention and treatment of sexually transmitted diseases-I
04/17/2012US8158560 Insecticidal arylpyrroline compounds
04/17/2012US8158416 CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins
04/17/2012US8158372 Agonists of a bitter taste receptor and uses thereof
04/17/2012US8158184 Structured lipid containing compositions and methods with health and nutrition promoting characteristics
04/17/2012US8158162 Eutectic-based self-nanoemulsified drug delivery system
04/17/2012US8158160 Anti-inflammatory cyclooxygenase inhibitors
04/17/2012US8158159 Pharmaceutical formulation for treating tinea of feet and hands and preparation thereof
04/17/2012US8158158 Composite biocidal particles
04/17/2012US8158154 Control particle size distribution; bioavailability; administering corticosteroid
04/17/2012US8158153 Nanoparticulate bisphosphonate compositions
04/17/2012US8158149 Threo-DOPS controlled release formulation
04/17/2012US8158148 Pharmaceutical tablets comprising two or more unitary segments
04/17/2012US8158147 Modified release formulations of at least one form of tramadol
04/17/2012US8158145 Multilayer transdermal laminate patch with backing, adhesive
04/17/2012US8158142 3-deazaadenosine prevents atherosclerosis and graft vasculopathy
04/17/2012US8158139 Topical gel formulation comprising organophosphate insecticide and preparation thereof
04/17/2012US8158138 Urea compositions and their methods of manufacture
04/17/2012US8158137 Functional nanomaterials with antibacterial and antiviral activity
04/17/2012US8158117 Methods and compositions for phosphate binding
04/17/2012CA2759063C 4-[(3-chloro-4-fluorophenyl)amino]-6-{[4-(n,n-dimethylamino)-1-oxo-2-buten-1-yl]amino}-7-((s)-tetrahydrofuran-3-yloxy)-quinazoline dimaleate and the use thereof
04/17/2012CA2702047C Substituted biphenyl gpr40 modulators
04/17/2012CA2695291C Substituted bicyclolactam compounds
04/17/2012CA2685303C Use of ivabradine in the coronary angiography procedure using multi-slice tomodensitometry
04/17/2012CA2676082C Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract
04/17/2012CA2667387C New benzamide derivatives as bradykinin antagonists
04/17/2012CA2662305C Heterocyclic gpr40 modulators
04/17/2012CA2660151C Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
04/17/2012CA2657670C Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of inflammation
04/17/2012CA2629670C Scored dosage form allowing modified release of the active ingredient
04/17/2012CA2627292C Hydrophilic vehicle-based dual controlled release matrix system
04/17/2012CA2614777C Rapid onset and short term modafinil compositions and methods of use thereof
04/17/2012CA2599328C Quinazoline derivative having tyrosine kinase inhibitory activity
04/17/2012CA2593428C Pyrrolopyrazoles, potent kinase inhibitors
04/17/2012CA2592436C Antithrombotic dual inhibitors comprising a biotin residue
04/17/2012CA2586689C 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
04/17/2012CA2585705C Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
04/17/2012CA2582447C Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
04/17/2012CA2570307C Alpha-amino acid derivatives with antiinflammatory activity
04/17/2012CA2569840C New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
1 ... 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 ... 7860